Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for NUWE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 9.126M
March 31, 2026 6.961M
December 31, 2025 6.118M
September 30, 2025 7.984M
June 30, 2025 9.20M
March 31, 2025 7.006M
December 31, 2024 9.864M
September 30, 2024 6.728M
June 30, 2024 6.189M
March 31, 2024 6.662M
December 31, 2023 9.77M
September 30, 2023 11.43M
June 30, 2023 15.55M
March 31, 2023 18.48M
December 31, 2022 24.67M
September 30, 2022 18.44M
June 30, 2022 22.00M
March 31, 2022 26.11M
December 31, 2021 30.42M
September 30, 2021 34.10M
June 30, 2021 29.64M
March 31, 2021 33.56M
December 31, 2020 20.01M
September 30, 2020 23.72M
June 30, 2020 13.14M
Date Value
March 31, 2020 10.05M
December 31, 2019 5.602M
September 30, 2019 7.584M
June 30, 2019 11.43M
March 31, 2019 15.36M
December 31, 2018 8.776M
September 30, 2018 11.79M
June 30, 2018 10.94M
March 31, 2018 14.41M
December 31, 2017 18.46M
September 30, 2017 9.34M
June 30, 2017 11.80M
March 31, 2017 7.822M
December 31, 2016 7.471M
September 30, 2016 6.621M
June 30, 2016 13.00M
March 31, 2016 17.78M
December 31, 2015 24.57M
September 30, 2015 29.37M
June 30, 2015 34.91M
March 31, 2015 38.80M
December 31, 2014 32.37M
September 30, 2014 37.79M
June 30, 2014 43.37M
March 31, 2014 48.88M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
GlucoTrack, Inc. 1.495M
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M

Total Assets (Quarterly) Related Metrics